Constance Keyserling
Chief Operating Officer presso ABIONYX PHARMA
Profilo
Constance Keyserling is currently the Director of Clinical Development & Operations at ABIONYX Pharma SA. Previously, she held positions as the Senior Director of Operations at Esperion Therapeutics, Inc., Manager of Clinical Research Operations at Pfizer Inc., Vice President of Development Operations at QuatRx Pharmaceuticals Co., and Manager of Clinical Research Operations at Parke, Davis & Co. LLC.
She obtained her graduate degree from Harvard University in 1984.
Posizioni attive di Constance Keyserling
Società | Posizione | Inizio |
---|---|---|
ABIONYX PHARMA | Chief Operating Officer | - |
Precedenti posizioni note di Constance Keyserling
Società | Posizione | Fine |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | - |
ESPERION THERAPEUTICS, INC. | Chief Operating Officer | - |
Parke, Davis & Co. LLC | Corporate Officer/Principal | - |
QuatRx Pharmaceuticals Co.
QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Corporate Officer/Principal | - |
Formazione di Constance Keyserling
Harvard University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
PFIZER, INC. | Health Technology |
ESPERION THERAPEUTICS, INC. | Health Technology |
ABIONYX PHARMA | Health Technology |
Aziende private | 2 |
---|---|
QuatRx Pharmaceuticals Co.
QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Health Technology |
Parke, Davis & Co. LLC |
- Borsa valori
- Insiders
- Constance Keyserling